Evaluation of the mobility of the shoulder and quality of life after perforator flaps for recalcitrant axillary hidradenitis

Hidradenitis suppurativa is a very debilitating disease, treated by antibiotics and excision. The reconstruction is usually done by secondary wound healing and/or split-thichness skin graft. The aim of this study was to evaluate the reconstruction of the axilla with local perforator flaps as a single stage surgical treatment. This was a monocentric retrospective study conducted between November 2013 and June 2015. We included the patients with a severe axillary localization of the disease. Between 6 months and 1 year postoperatively, we noted length of complete healing, complications, patients satisfaction score about the surgery, DASH functional score, maximum abduction angle of the arm, and recurrence of the disease. Thirteen patients were included, for a total of seventeen affected axillae. We performed seven thoracodorsal artery perforator flaps, seven lateral intercostal artery perforator flaps and three serratus anterior artery perforator flaps. The mean duration of follow-up was 279.1±84.1 days (180–365). The average complete healing time was 20.5±13.5 days (10–60). Six axillae were compounded (35%). The average recurrence rate of HS was 0%. The average score in the DASH questionnaire was 68.6±35.3 points (39–152) and the average maximum abduction angle of the arm was 160.6±18.5 degrees. The average score on the satisfaction questionnaire was 36.5±5.6 points (25–43). This is a single stage, reliable and effective surgical procedure. The results are very encouraging, with a good quality of life, a low functional disability and a shorter healing time. La maladie de Verneuil est une pathologie chronique inflammatoire invalidante, traitée par antibiotiques et exérèse chirurgicale. La reconstruction après exérèse est habituellement faite par cicatrisation dirigée et/ou greffe de peau mince. L’objectif de cette étude est d’évaluer la reconstruction du creux axillaire avec des lambeaux perforants pédiculés. Il s’agit d’une étude rétrospective monocentrique réalisée entre novembre 2013 et juin 2015. Nous avons inclus tous les patients ayant une maladie de Verneuil axillaire sévère, nécessitant une intervention. Six mois à 1 an postopératoires, nous avons noté le temps de cicatrisation, les complications, le score de satisfaction sur la qualité de vie, le score fonctionnel DASH, l’angle d’abduction maximal de l’épaule et la récurrence ou non de la maladie. Treize patients ont été inclus (17 creux axillaires atteints). Nous avons réalisé 7 lambeaux perforants